e-learning
resources
Berlin 2008
Monday, 06.10.2008
The challenge of multidrug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The compare of the TB-Biochip oligonucleotide microarray system and bacteriological method for detection of rifampin and isoniazid resistance in mycobacterium tuberculosis
J. Isakova, Z. Goncharova, A. Aldashev (Bishkek, Kyrgyzstan)
Source:
Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Session:
The challenge of multidrug-resistant tuberculosis
Session type:
Thematic Poster Session
Number:
2494
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Isakova, Z. Goncharova, A. Aldashev (Bishkek, Kyrgyzstan). The compare of the TB-Biochip oligonucleotide microarray system and bacteriological method for detection of rifampin and isoniazid resistance in mycobacterium tuberculosis. Eur Respir J 2008; 32: Suppl. 52, 2494
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Evaluation of a molecular assay for detection of rifampin and isoniazid resistant
mycobacterium tuberculosis
in strains and clinical samples
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Detection of isoniazid or rifampin resistant
Mycobacterium tuberculosis
in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Evaluation of a line probe assay kit for direct and simultaneous detection of mycobacterium tuberculosis complex and its resistance to rifampin
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Xpert MTB/RIF assay for rapid detection of Mycobacterium tuberculosis and rifampicin resistance
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Determination of drug susceptibility of
Mycobacterium tuberculosis
through mycolic acid analysis with HPLC technique - comparison to the conventional methods
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005
Comparison of rapid in-house methods for drug susceptibility testing of
mycobacterium tuberculosis
with gold standards
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007
Rapid genotypic assays for detection the rifampin and isoniazid resistance in
M. tuberculosis
strains and clinical specimens in Moldova
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010
The results of drug susceptibility testing of mycobacterium tuberculosis to rifampicin by Xpert® MTB / Rif, BACTEC MGIT 960 as compared with the method of seeding on solid nutrient media
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016
Rapid resistance detection of
Mycobacterium tuberculosis
to second-line drugs using the manual mycobacterium growth indicator tube (MGIT) system.
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008
Direct molecular testing for isoniazid and rifampicin resistance from respiratory specimens of patients with tuberculosis
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013
Rapid diagnosis of tuberculosis and rifampin resistance by GeneXpert MTB/RIF test
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
Development of real-time PCR technique for detection of the
M.tuberculosis
DNA mutations associated with fluoroquinolones drug resistance
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
Usefulness of a new molecular method to detect fluoroquinolones, kanamycin, capreomycin and ethambutol resistance in TB clinical isolates and direct specimens
Source: Annual Congress 2010 - Tuberculosis: from bench to bedside
Year: 2010
GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis
Source: Eur Respir J 2008; 32: 1165-1174
Year: 2008
Application of the method of biological microchips for control drug-resistant mycobacterium tuberculosis
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Rapid molecular detection of rifampicin and isoniazid resistance and identification of mutations in resistant genes of multi-drug resistant tuberculosis (MDR-TB) patients
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011
Analysis of melting temperatures in defining resistance to isoniazid and rifampicin by PCR based techniques
Source: Eur Respir J 2006; 28: Suppl. 50, 525s
Year: 2006
Detection of fluoroquinolone resistance associated mutations in Mycobacterium tuberculosis by use of sequencing and TaqMan probes
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Comparison of genotype MTBDRplus assay for rapid detection of rifampicin and isoniazid resistance with conventional drug susceptibility tests in a tertiary care hospital in India
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept